{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:50Z","timestamp":1792686290518,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"crossref","award":["17\/71\/04"],"award-info":[{"award-number":["17\/71\/04"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>New-onset atrial fibrillation (NOAF) in patients treated on an intensive care unit (ICU) is common and associated with significant morbidity and mortality. We undertook a systematic scoping review to summarise comparative evidence to inform NOAF management for patients admitted to ICU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched MEDLINE, EMBASE, CINAHL, Web of Science, OpenGrey, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, ISRCTN, ClinicalTrials.gov, EU Clinical Trials register, additional WHO ICTRP trial databases, and NIHR Clinical Trials Gateway in March 2019. We included studies evaluating treatment or prevention strategies for NOAF or acute anticoagulation in general medical, surgical or mixed adult ICUs. We extracted study details, population characteristics, intervention and comparator(s), methods addressing confounding, results, and recommendations for future research onto study-specific forms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 3,651 citations, 42 articles were eligible: 25 primary studies, 12 review articles and 5 surveys\/opinion papers. Definitions of NOAF varied between NOAF lasting 30\u00a0s to NOAF lasting\u2009&gt;\u200924\u00a0h. Only one comparative study investigated effects of anticoagulation. Evidence from small RCTs suggests calcium channel blockers (CCBs) result in slower rhythm control than beta blockers (1 study), and more cardiovascular instability than amiodarone (1 study). Evidence from 4 non-randomised studies suggests beta blocker and amiodarone therapy may be equivalent in respect to rhythm control. Beta blockers may be associated with improved survival compared to amiodarone, CCBs, and digoxin, though supporting evidence is subject to confounding. Currently, the limited evidence does not support therapeutic anticoagulation during ICU admission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>From the limited evidence available beta blockers or amiodarone may be superior to CCBs as first line therapy in undifferentiated patients in ICU. The little evidence available does not support therapeutic anticoagulation for NOAF whilst patients are critically ill. Consensus definitions for NOAF, rate and rhythm control are needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-021-03684-5","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T12:03:35Z","timestamp":1626869015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-4189","authenticated-orcid":false,"given":"Laura","family":"Drikite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Bedford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"O\u2019Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Petrinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Rajappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Doidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Mouncey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Watkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"issue":"9","key":"3684_CR1","doi-asserted-by":"publisher","first-page":"e024640","DOI":"10.1136\/bmjopen-2018-024640","volume":"8","author":"J Bedford","year":"2018","unstructured":"Bedford J, Harford M, Petrinic T, Young JD, Watkinson PJ. Risk factors for new-onset atrial fibrillation on the general adult ICU: protocol for a systematic review. BMJ Open. 2018;8(9):e024640.","journal-title":"BMJ Open"},{"issue":"12","key":"3684_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/00003246-199012000-00015","volume":"18","author":"H Artucio","year":"1990","unstructured":"Artucio H, Pereira M. Cardiac arrhythmias in critically ill patients: epidemiologic study. Crit Care Med. 1990;18(12):1383\u20138.","journal-title":"Crit Care Med"},{"issue":"3","key":"3684_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.CCM.0000114579.56430.E0","volume":"32","author":"P Seguin","year":"2004","unstructured":"Seguin P, Signouret T, Laviolle B, Branger B, Mall\u00e9dant Y. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med. 2004;32(3):722\u20136.","journal-title":"Crit Care Med"},{"issue":"7","key":"3684_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s001340051280","volume":"26","author":"H Knotzer","year":"2000","unstructured":"Knotzer H, Mayr A, Ulmer H, Lederer W, Schobersberger W, Mutz N, et al. Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med. 2000;26(7):908\u201314.","journal-title":"Intensive Care Med"},{"issue":"3","key":"3684_CR5","doi-asserted-by":"publisher","first-page":"326.e1","DOI":"10.1016\/j.jcrc.2011.10.011","volume":"27","author":"S Kanji","year":"2012","unstructured":"Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012;27(3):326.e1-8.","journal-title":"J Crit Care"},{"issue":"1","key":"3684_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40560-015-0085-4","volume":"3","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Fujii T, Uchino S, Takinami M. Epidemiology, prevention, and treatment of new-onset atrial fibrillation in critically ill: a systematic review. J Intensive Care. 2015;3(1):19.","journal-title":"J Intensive Care"},{"issue":"6","key":"3684_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","volume":"18","author":"S Kuipers","year":"2014","unstructured":"Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care. 2014;18(6):688.","journal-title":"Crit Care"},{"issue":"3","key":"3684_CR8","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/cc9057","volume":"14","author":"R Meierhenrich","year":"2010","unstructured":"Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, B\u00f6gelein D, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Critical Care (Lond, Engl). 2010;14(3):R108.","journal-title":"Critical Care (Lond, Engl)"},{"issue":"4","key":"3684_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7861\/clinmedicine.18-4-282","volume":"18","author":"B Clayton","year":"2018","unstructured":"Clayton B, Ball S, Read J, Waddy S. Risk of thromboembolism in patients developing critical illness-associated atrial fibrillation. Clin Med (Lond). 2018;18(4):282\u20137.","journal-title":"Clin Med (Lond)"},{"issue":"7","key":"3684_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00134-019-05633-x","volume":"45","author":"M Wetterslev","year":"2019","unstructured":"Wetterslev M, Haase N, Hassager C, Belley-Cote EP, McIntyre WF, An Y, et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review. Intensive Care Med. 2019;45(7):928\u201338.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3684_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-020-2730-0","volume":"24","author":"SM Fernando","year":"2020","unstructured":"Fernando SM, Mathew R, Hibbert B, Rochwerg B, Munshi L, Walkey AJ, et al. New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study. Crit Care. 2020;24(1):15.","journal-title":"Crit Care"},{"key":"3684_CR12","unstructured":"Atrial fibrillation: management. National Institute for Health and Care Excellence; 2014."},{"issue":"5","key":"3684_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"4","key":"3684_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1378\/chest.15-0358","volume":"148","author":"AJ Walkey","year":"2015","unstructured":"Walkey AJ, Hogarth DK, Lip GYH. Optimizing atrial fibrillation management: from ICU and beyond. Chest. 2015;148(4):859\u201364.","journal-title":"Chest"},{"issue":"10","key":"3684_CR15","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1177\/1060028013500938","volume":"47","author":"OS Darwish","year":"2013","unstructured":"Darwish OS, Strube S, Nguyen HM, Tanios MA. Challenges of anticoagulation for atrial fibrillation in patients with severe sepsis. Ann Pharmacother. 2013;47(10):1266\u201371.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"3684_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/SHK.0000000000000869","volume":"48","author":"A Moskowitz","year":"2017","unstructured":"Moskowitz A, Chen KP, Cooper AZ, Chahin A, Ghassemi MM, Celi LA. Management of atrial fibrillation with rapid ventricular response in the intensive care unit: a secondary analysis of electronic health record data. Shock. 2017;48(4):436\u201340.","journal-title":"Shock"},{"key":"3684_CR17","doi-asserted-by":"publisher","first-page":"e3716","DOI":"10.7717\/peerj.3716","volume":"5","author":"CS Chean","year":"2017","unstructured":"Chean CS, McAuley D, Gordon A, Welters ID. Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey. PeerJ. 2017;5:e3716.","journal-title":"PeerJ"},{"key":"3684_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jcrc.2019.06.015","volume":"53","author":"JP Bedford","year":"2019","unstructured":"Bedford JP, Harford M, Petrinic T, Young JD, Watkinson PJ. Risk factors for new-onset atrial fibrillation on the general adult ICU: A systematic review. J Crit Care. 2019;53:169\u201375.","journal-title":"J Crit Care"},{"issue":"5","key":"3684_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00540-018-2537-1","volume":"32","author":"T Yokota","year":"2018","unstructured":"Yokota T, Uchino S, Yoshida T, Fujii T, Takinami M. Predictors for sustained new-onset atrial fibrillation in critically ill patients: a retrospective observational study. J Anesth. 2018;32(5):681\u20137.","journal-title":"J Anesth"},{"key":"3684_CR20","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"3684_CR21","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"issue":"5","key":"3684_CR22","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/00000542-199811000-00004","volume":"89","author":"JR Balser","year":"1998","unstructured":"Balser JR, Martinez EA, Winters BD, Perdue PW, Clarke AW, Huang W, et al. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology. 1998;89(5):1052\u20139.","journal-title":"Anesthesiology"},{"issue":"6","key":"3684_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","volume":"29","author":"G Delle Karth","year":"2001","unstructured":"Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med. 2001;29(6):1149\u201353.","journal-title":"Crit Care Med"},{"key":"3684_CR24","unstructured":"Gerlach A, Kane-Gill S, F Dasta J, Steinberg S, C Martin L, Cook C. Diltiazem versus amiodarone for new-onset atrial arrhythmias in non-cardiac post surgical patients: a cohort study 2008."},{"issue":"3","key":"3684_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0885066617696847","volume":"34","author":"Y Launey","year":"2019","unstructured":"Launey Y, Lasocki S, Asehnoune K, Gaudriot B, Chassier C, Cinotti R, et al. Impact of low-dose hydrocortisone on the incidence of atrial fibrillation in patients with septic shock: a propensity score-inverse probability of treatment weighting cohort study. J Intensive Care Med. 2019;34(3):238\u201344.","journal-title":"J Intensive Care Med"},{"key":"3684_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcrc.2017.04.027","volume":"41","author":"M Balik","year":"2017","unstructured":"Balik M, Kolnikova I, Maly M, Waldauf P, Tavazzi G, Kristof J. Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol. J Crit Care. 2017;41:16\u201323.","journal-title":"J Crit Care"},{"issue":"Suppl_1","key":"3684_CR27","first-page":"A20382-A","volume":"136","author":"MS Cho","year":"2017","unstructured":"Cho MS, Nam G-B, Kim YN, Hwang J, Kim M, Lee JH, et al. Abstract 20382: Comparison of Outcomes After Rhythm or Rate Control Strategy for the New-Onset Atrial Fibrillation in Critically Ill Sepsis Patients Managed in the Medical Intensive Care Unit. Circulation. 2017;136(Suppl_1):A20382-A.","journal-title":"Circulation"},{"issue":"4","key":"3684_CR28","doi-asserted-by":"publisher","first-page":"361A","DOI":"10.1016\/j.chest.2016.08.374","volume":"150","author":"F Jaffer","year":"2016","unstructured":"Jaffer F, Anand S, Ajay-obe A, Parbtani R, Doraiswamy V, Malo J. Use of Amiodarone in Management of Atrial Tachyarrhythmia in Septic Shock. Chest. 2016;150(4):361A.","journal-title":"Chest"},{"key":"3684_CR29","doi-asserted-by":"crossref","unstructured":"Kane S, Hanes S, editors. 946: Impact of hydrocortisone on atrial fibrillation in septic shock 2014.","DOI":"10.1097\/01.ccm.0000458443.11317.7a"},{"key":"3684_CR30","doi-asserted-by":"crossref","unstructured":"Matsumoto Y, Shibata SC, Maeda A, Imada T, Okitsu K, Fujino Y. Comparison of the short acting beta1 blocker landiolol with amiodarone for pharmacological cardioversion for atrial fibrillation in intensive care unit patients. 2015 annual meeting of the international anesthesia research society, IARS 2015 Honolulu, HI United States. 2015;120(3 SUPPL. 1):S109.","DOI":"10.1213\/01.ane.0000470325.07465.0f"},{"key":"3684_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jss.2018.03.009","volume":"229","author":"M Brown","year":"2018","unstructured":"Brown M, Nassoiy S, Chaney W, Plackett TP, Blackwell RH, Luchette F, et al. Impact and treatment success of new-onset atrial fibrillation with rapid ventricular rate development in the surgical intensive care unit. J Surg Res. 2018;229:66\u201375.","journal-title":"J Surg Res"},{"key":"3684_CR32","unstructured":"Mieure KD, Moranville MP, Park JJ, Lat I, Jennings HR, Lazar S, et al. A comparison of intravenous rate control agents for new onset atrial fibrillation with rapid ventricular rate. 32nd Annual Scientific Sessions of the Heart Rhythm Society, Heart Rhythm San Francisco, CA United States. 2011;8(5 SUPPL. 1):S216-S7."},{"issue":"1","key":"3684_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1378\/chest.15-0959","volume":"149","author":"AJ Walkey","year":"2016","unstructured":"Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: a propensity-matched cohort study. Chest. 2016;149(1):74\u201383.","journal-title":"Chest"},{"issue":"6","key":"3684_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamacardio.2016.2181","volume":"1","author":"AJ Walkey","year":"2016","unstructured":"Walkey AJ, Quinn EK, Winter MR, McManus DD, Benjamin EJ. Practice patterns and outcomes associated with use of anticoagulation among patients with atrial fibrillation during sepsis. JAMA Cardiol. 2016;1(6):682\u201390.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"3684_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00508-004-0297-4","volume":"117","author":"G Delle Karth","year":"2005","unstructured":"Delle Karth G, Schillinger M, Geppert A, Haumer M, Gwechenberger M, Meyer B, et al. Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population. Wien Klin Wochenschr. 2005;117(3):92\u20137.","journal-title":"Wien Klin Wochenschr"},{"issue":"7","key":"3684_CR36","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-002-1317-3","volume":"28","author":"MG Hennersdorf","year":"2002","unstructured":"Hennersdorf MG, Perings SM, Zuhlke C, Heidland UE, Perings C, Heintzen MP, et al. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Intensive Care Med. 2002;28(7):925\u20139.","journal-title":"Intensive Care Med"},{"issue":"2","key":"3684_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/01.CCM.0000048627.39686.79","volume":"31","author":"A Mayr","year":"2003","unstructured":"Mayr A, Ritsch N, Knotzer H, Dunser M, Schobersberger W, Ulmer H, et al. Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients. Crit Care Med. 2003;31(2):401\u20135.","journal-title":"Crit Care Med"},{"issue":"5","key":"3684_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00540-016-2199-9","volume":"30","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Inokuchi R, Hiruma T, Tokunaga K, Doi K, Nakajima S. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia. J Anesth. 2016;30(5):891\u20134.","journal-title":"J Anesth"},{"issue":"12","key":"3684_CR39","first-page":"A137-A","volume":"31","author":"RS Slavik","year":"2003","unstructured":"Slavik RS, de Lemos J, Gorman SK, Buchkowsky S. Patterns of practice for the acute management of new-onset atrial fibrillation in critically-ill intensive care unit patients. Crit Care Med. 2003;31(12):A137-A.","journal-title":"Crit Care Med"},{"issue":"1","key":"3684_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0885066607310181","volume":"23","author":"ME Sleeswijk","year":"2008","unstructured":"Sleeswijk ME, Tulleken JE, Van Noord T, Meertens JH, Ligtenberg JJ, Zijlstra JG. Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study. J Intensive Care Med. 2008;23(1):61\u20136.","journal-title":"J Intensive Care Med"},{"issue":"5","key":"3684_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.amjsurg.2010.07.019","volume":"200","author":"JM Burris","year":"2010","unstructured":"Burris JM, Subramanian A, Sansgiry S, Palacio CH, Bakaeen FG, Awad SS. Perioperative atrial arrhythmias in noncardiothoracic patients: a review of risk factors and treatment strategies in the veteran population. Am J Surg. 2010;200(5):601\u20135.","journal-title":"Am J Surg"},{"issue":"1","key":"3684_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0310057X18811815","volume":"47","author":"M Kyo","year":"2019","unstructured":"Kyo M, Hosokawa K, Ohshimo S, Kida Y, Tanabe Y, Ota K, et al. High serum potassium level is associated with successful electrical cardioversion for new-onset atrial fibrillation in the intensive care unit: A retrospective observational study. Anaesth Intensive Care. 2019;47(1):52\u20139.","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"3684_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13054-016-1548-2","volume":"20","author":"WC Liu","year":"2016","unstructured":"Liu WC, Lin WY, Lin CS, Huang HB, Lin TC, Cheng SM, et al. Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation. Crit Care (Lond, Engl). 2016;20(1):373.","journal-title":"Crit Care (Lond, Engl)"},{"issue":"9\u201310","key":"3684_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/BF03040901","volume":"116","author":"AJ Mayr","year":"2004","unstructured":"Mayr AJ, Dunser MW, Ritsch N, Pajk W, Friesenecker B, Knotzer H, et al. High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study. Wien Klin Wochenschr. 2004;116(9\u201310):310\u20137.","journal-title":"Wien Klin Wochenschr"},{"key":"3684_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13054-016-1252-2","volume":"20","author":"G Mitric","year":"2016","unstructured":"Mitric G, Udy A, Bandeshe H, Clement P, Boots R. Variable use of amiodarone is associated with a greater risk of recurrence of atrial fibrillation in the critically ill. Crit Care. 2016;20:90.","journal-title":"Crit Care"},{"issue":"6","key":"3684_CR46","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","volume":"154","author":"NA Bosch","year":"2018","unstructured":"Bosch NA, Cimini J, Walkey AJ. Atrial Fibrillation in the ICU. Chest. 2018;154(6):1424\u201334.","journal-title":"Chest"},{"issue":"5","key":"3684_CR47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5603\/AIT.a2017.0061","volume":"49","author":"M Balik","year":"2017","unstructured":"Balik M, Matousek V, Maly M, Brozek T. Management of arrhythmia in sepsis and septic shock. Anaesthesiol Intensive Therapy. 2017;49(5):419\u201329.","journal-title":"Anaesthesiol Intensive Therapy"},{"issue":"5","key":"3684_CR48","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1097\/CCM.0b013e3181709e43","volume":"36","author":"S Kanji","year":"2008","unstructured":"Kanji S, Stewart R, Fergusson DA, McIntyre L, Turgeon AF, Hebert PC. Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials. Crit Care Med. 2008;36(5):1620\u20134.","journal-title":"Crit Care Med"},{"issue":"10","key":"3684_CR49","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s00101-017-0334-0","volume":"66","author":"M Keller","year":"2017","unstructured":"Keller M, Meierhenrich R. New onset atrial fibrillation in patients with sepsis. Anaesthesist. 2017;66(10):786\u201394.","journal-title":"Anaesthesist"},{"issue":"Suppl A","key":"3684_CR50","doi-asserted-by":"publisher","first-page":"A15","DOI":"10.1093\/eurheartj\/sux039","volume":"20","author":"S Rehberg","year":"2018","unstructured":"Rehberg S, Joannidis M, Whitehouse T, Morelli A. Landiolol for managing atrial fibrillation in intensive care. Eur Heart J Suppl. 2018;20(Suppl A):A15\u20138.","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"3684_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1155\/2015\/394961","volume":"22","author":"S Sibley","year":"2015","unstructured":"Sibley S, Muscedere J. New-onset atrial fibrillation in critically ill patients. Can Respir J. 2015;22(3):179\u201382.","journal-title":"Can Respir J"},{"issue":"6","key":"3684_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/cc6136","volume":"11","author":"ME Sleeswijk","year":"2007","unstructured":"Sleeswijk ME, Van Noord T, Tulleken JE, Ligtenberg JJ, Girbes AR, Zijlstra JG. Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients\u2013a clinical framework. Critical care (Lond, Engl). 2007;11(6):233.","journal-title":"Critical care (Lond, Engl)"},{"key":"3684_CR53","doi-asserted-by":"crossref","unstructured":"Schwartz A, Brotfain E, Koyfman L, Klein M. Cardiac arrhythmias in a septic ICU population: a review. J Crit Care Med (Universitatea de Medicina si Farmacie din Targu-Mures). 2015;1(4):140\u20136.","DOI":"10.1515\/jccm-2015-0027"},{"issue":"4","key":"3684_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1944451612449649","volume":"3","author":"WA Shapiro","year":"2012","unstructured":"Shapiro WA, Schulze K. An algorithm for the practical management of the new onset of atrial fibrillation in patients admitted to the ICU. ICU Dir. 2012;3(4):179\u201384.","journal-title":"ICU Dir"},{"key":"3684_CR55","unstructured":"Tran B. Atrial fibrillation in sepsis: should we worry? Relias Media. 2018."},{"issue":"4","key":"3684_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.acvd.2015.01.001","volume":"108","author":"V Labbe","year":"2015","unstructured":"Labbe V, Ederhy S, Fartoukh M, Cohen A. Should we administrate anticoagulants to critically ill patients with new onset supraventricular arrhythmias? Arch Cardiovasc Dis. 2015;108(4):217\u20139.","journal-title":"Arch Cardiovasc Dis"},{"issue":"5","key":"3684_CR57","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/CCM.0b013e31817014d2","volume":"36","author":"RG Trohman","year":"2008","unstructured":"Trohman RG. Atrial fibrillation in the critically ill: common sense for a common problem. Crit Care Med. 2008;36(5):1681\u20132.","journal-title":"Crit Care Med"},{"issue":"5","key":"3684_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bjaed\/mkw055","volume":"17","author":"PR Knowles","year":"2017","unstructured":"Knowles PR, Press C. Anaesthesia for cardioversion. BJA Educ. 2017;17(5):166\u201371.","journal-title":"BJA Educ"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-021-03684-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03684-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:20:38Z","timestamp":1626873638000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-021-03684-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3684"],"URL":"https:\/\/doi.org\/10.1186\/s13054-021-03684-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Paul Mouncey, Kathryn Rowan, and David Harrison have received grants from National Institute for Health Research. Peter Watkinson worked part time for Sensyne Health and has received grant funding from National Institute for Health Research, Wellcome, and Sensyne Health outside the submitted work. No other authors had competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}